COZZI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 3.256
EU - Europa 1.628
AS - Asia 1.149
SA - Sud America 104
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 21
Totale 6.206
Nazione #
US - Stati Uniti d'America 3.220
RU - Federazione Russa 652
SG - Singapore 320
IT - Italia 289
HK - Hong Kong 261
CN - Cina 241
IE - Irlanda 155
VN - Vietnam 126
SE - Svezia 124
UA - Ucraina 83
KR - Corea 81
DE - Germania 78
BR - Brasile 77
FR - Francia 62
FI - Finlandia 48
GB - Regno Unito 45
TR - Turchia 37
IN - India 26
CA - Canada 23
PL - Polonia 22
AU - Australia 21
CH - Svizzera 20
BE - Belgio 14
BD - Bangladesh 12
JO - Giordania 11
JP - Giappone 10
AR - Argentina 8
CI - Costa d'Avorio 8
NL - Olanda 8
BG - Bulgaria 7
RO - Romania 7
ZA - Sudafrica 7
EC - Ecuador 5
ID - Indonesia 5
CO - Colombia 4
ES - Italia 4
MX - Messico 4
SA - Arabia Saudita 4
SC - Seychelles 4
VE - Venezuela 4
CL - Cile 3
IL - Israele 3
IQ - Iraq 3
BY - Bielorussia 2
HN - Honduras 2
MA - Marocco 2
NG - Nigeria 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GR - Grecia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UG - Uganda 1
Totale 6.185
Città #
Santa Clara 682
Ashburn 346
Fairfield 291
Hong Kong 229
Singapore 203
Chandler 193
Dublin 155
Woodbridge 131
Cambridge 127
Jacksonville 123
Houston 122
Seattle 107
Wilmington 98
Seoul 80
Ann Arbor 78
San Jose 74
Beijing 73
Buffalo 60
Milan 54
Los Angeles 45
Altamura 41
Lauterbourg 40
Princeton 39
Ho Chi Minh City 38
Council Bluffs 36
Lawrence 36
Boardman 35
The Dalles 33
Boston 28
Rome 25
Shanghai 25
Hanoi 24
Hefei 24
Warsaw 22
Melbourne 21
Bern 20
New York 20
San Diego 19
Dong Ket 18
Mumbai 17
Washington 17
Florence 15
Brussels 14
Medford 14
Dallas 13
Izmir 13
Paris 13
Guangzhou 11
Munich 11
Portsmouth 11
Norwalk 10
Tokyo 10
Da Nang 9
Frankfurt am Main 9
London 9
Toronto 9
Abidjan 8
Helsinki 8
Naples 8
Brooklyn 7
Chicago 7
Columbus 7
Moscow 7
Johannesburg 6
Orem 6
São Paulo 6
Timisoara 6
Auburn Hills 5
Denver 5
Figino 5
Kent 5
Redondo Beach 5
Sofia 5
Turin 5
Verona 5
Andover 4
Cagliari 4
Dhaka 4
Düsseldorf 4
Hillsboro 4
Iesi 4
Rio de Janeiro 4
Salerno 4
Yubileyny 4
Amman 3
Bologna 3
Clifton 3
Heidelberg 3
Jeddah 3
Miami 3
Miano 3
Modena 3
Newark 3
Palermo 3
Pescara 3
Quito 3
Shenzhen 3
Tianjin 3
Turku 3
Abuja 2
Totale 4.219
Nome #
HCV Patients Psychopathology and Tryptophan Metabolism: Analysis of the Effects of Pegylated Interferon plus Ribavirin Treatment 261
Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery. 247
Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to post-ischemic neuronal injury in vitro and in vivo. 209
Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany 202
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study 202
Acute phencyclidine administration reduces extracellular glutamate levels and the expression of synaptophysin and SNAP-25 in rat frontal cortex 201
Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase. 192
1-Amino-1,5-dicarboxylic acid and (S)-(+)-2-(3'-carboxybicyclo[1.1.1]pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischemia 185
Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro. 184
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients 176
Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors 176
Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. 174
NAPOR-3 RNA binding protein is required for apoptosis in hippocampus 173
Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia 170
Tryptophan/kynurenine pathway changes in HCV-infected patients: possible involvement in associated neuropsychiatry pathology 169
GAT-1 regulates both tonic and phasic GABAA receptor-mediated inhibition in the cerebral cortex 168
The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine 167
Presynaptic kynurenate-sensitive receptors inhibit glutamate release. 167
Poly (ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia 162
Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia. 162
GPR35 is functionally expressed in astrocytes and mediates kynurenic acid-dependent reduction of excitatory synaptic activity at CA3-CA1 synapse. 162
Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors 160
Alteration of the subcellular and tissue distribution of ELAV-type proteins during cerebral ischemia in the rat 153
Poly(ADP-ribose) accumulation and enhancement of postischemic brain damage in 110-kDa poly(ADP-ribose) glycohydrolase null mice. 151
Transient focal ischemia triggers neuronal expression of GAT-3 in the rat perilesional cortex 150
Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus 148
Neuroprotective effects of propofol in models of cerebral ischemia: inhibition of mitochondrial swelling as a possible mechanism. 146
Tryptophan/Kynurenine pathway changes in HCV infected patients: possible involvment in associated neuropsychiathy pathology. 146
Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage 140
Endocannabinoids play a crucial role in the mechanisms of mGlu1-mediated neuroprotection in models of cerebral ischemia. 136
Tryptophan/kynurenine Patway Changes in HCV-infected Patients: Possible Involvement In Associated Neuropsychiatry Pathology 130
Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity? 129
Interplay between group I mGlu receptors and the endocannabinoid system in the CA1 hippocampal area: studies in models of cerebral ischemia 129
GLT-1 expression and glutamate uptake in rat cerebral cortex are increased by phencyclidine 127
The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death 126
Kynurenic acid actions in brain and periphey 119
Protection with mGlu1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms 105
The glycine antagonist and free radical scavenger 7-Cl-thio-kynurenate reduces CA1 ischemic damage in the gerbil. 102
Totale 6.206
Categoria #
all - tutte 16.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022234 0 25 15 11 11 11 15 16 14 11 38 67
2022/2023740 65 120 42 57 67 133 101 39 65 5 17 29
2023/2024237 7 26 47 22 23 53 11 33 3 3 4 5
2024/20251.870 56 174 110 280 613 189 7 212 90 46 54 39
2025/20261.554 190 226 131 58 194 50 203 79 92 91 34 206
2026/2027102 52 50 0 0 0 0 0 0 0 0 0 0
Totale 6.206